Intrinsiqs

Is Seres Therapeutics, Inc. overvalued?

Seres Therapeutics, Inc. (MCRB) — key valuation metrics and fundamentals.

No verdict
Price
$3.52
Fair value
—
Current P/E
—
Normal P/E
—
Market cap
$34.1M
Dividend yield
0.0%
Return on equity
-60.3%
Sector
Healthcare

See the full interactive analysis →

Fair value compares MCRB's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 24 Sep 2026.